Skip to main content

Table 2 Responses to selected survey questions

From: Insights, attitudes, and perceptions about asthma and its treatment: findings from a multinational survey of patients from Latin America

Question Latin America (n=2,169) Argentina (n=436) Brazil (n=400) Mexico (n=532) Puerto Rico (n=401) Venezuela (n=400)
Daytime symptom frequency, %       
  Every day/most days 24 35 27 12 34 18
  1-2 days/week 22 25 20 20 15 29
  1-2 times/month 11 8 10 18 7 11
  No daytime symptoms 44 32 44 50 43 42
Nighttime symptom frequency, %       
  Every night/most nights 20 28 24 9 26 14
  1-2 nights/week 16 20 16 16 15 18
  1-2 times/month 10 8 11 12 5 10
  No nighttime symptoms 53 45 50 62 53 58
Subjects with episodes in the past 12 months with asthma symptoms more frequent or more severe than normal, % 47 57 46 42 61 48
Median number of episodes 2 3 2 3 3 3
Subjects who agreed with the following statements, %       
  Long-term control medicines should be taken every day 41 61 41 48 61 26
  Long-term control medicines are not necessary when asthma symptoms are not experienced regularly 65 55 67 54 59 72
  Quick relief medications can be used every day if needed 61 68 58 56 84 71
Subjects reporting ≥1 week of interrupted asthma controller medicine use, %       
  <2 weeks 26 32 26 29 15 21
  3-4 weeks 9 10 8 14 9 10
  ≥1 month 61 49 52 52 71 65
GINA 2009 asthma control levels       
  Well controlled, % 8 5 9 9 8 3
  Partly controlled, % 57 48 57 56 59 65
  Uncontrolled, % 35 57 34 35 33 32
  1. GINA=Global initiative for asthma.